Patient Demographics and Clinical Characteristics
Variable | Data |
Sex | |
Male | 9 (69.2) |
Female | 4 (30.8) |
Age (y) | 63 (51–71) |
Nephrectomy | |
Yes | 11 (84.6) |
No | 2 (15.4) |
Histology | |
Pure clear cell | 12 (92.3) |
Mixed | 1 (7.7) |
World Health Organization performance | |
0 | 4 (30.8) |
1 | 2 (15.4) |
2 | 7 (53.8) |
Tumor sites | |
Number | 4 (2–7) |
Kidney | 6 (46.2) |
Primary | 2 (15.4) |
Local recurrence | 2 (15.4) |
Contralateral | 2 (15.4) |
Lung | 9 (69.2) |
Lymph node | 7 (53.8) |
Bone | 6 (46.2) |
Liver | 5 (38.5) |
Adrenal | 4 (30.8) |
Muscle | 4 (30.8) |
Other | 10 (76.9) |
Previous treatment | |
Tyrosine kinase inhibitor | 8 (61.5) |
Tyrosine kinase inhibitor and interferon alfa ± bevacizumab | 2 (15.4) |
Other | 3 (23.1) |
Qualitative data are expressed as number followed by percentage in parentheses; continuous data are expressed as median followed by range in parentheses.